Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

1(25.0%)

Phase 2

1(25.0%)

4Total

N/A(2)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05485714Completed

Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis

Role: collaborator

NCT04763122Completed

Thyroid Cancer in United Arab Emirates

Role: lead

NCT02809170Not ApplicableCompleted

The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases

Role: lead

NCT02195778Unknown

Assessment of Health Literacy Among Adult Patients in the United Arab Emirates to Facilitate Clinical Trials Recruitment.

Role: lead

NCT01691365Phase 4Completed

Effects of Antioxidants and B Vitamins Supplements on Inflammation in Obese Diabetic Patients

Role: collaborator

NCT01429545Phase 2Completed

Single Versus Combination Therapy in Acute Tocolysis

Role: lead

NCT00336206Not ApplicableUnknown

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

Role: lead

All 7 trials loaded